What does everyone make of this dot point
Seems like as a monotherapy it's not so effective as when it was given as dual, where the benefit was clinically significant 4 weeks following. Also the Cd in dual is ~40% higher.
Though I'm a little confused as the above states this group had less severe depression but it is unclear what the group of 31 patients receiving Xananmem as a monotherapy was (severe depression, less severe or mix)
- Forums
- ASX - By Stock
- ACW
- Ann: ACW XanaCIDD phase 2a trial topline results
Ann: ACW XanaCIDD phase 2a trial topline results, page-44
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.5¢ |
Change
-0.002(7.41%) |
Mkt cap ! $67.79M |
Open | High | Low | Value | Volume |
2.8¢ | 2.8¢ | 2.5¢ | $542.4K | 20.60M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 5826241 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.6¢ | 200000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 5726241 | 0.025 |
13 | 3270454 | 0.024 |
9 | 691828 | 0.023 |
7 | 1984851 | 0.022 |
11 | 581551 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.026 | 200000 | 1 |
0.027 | 1007787 | 6 |
0.028 | 1108111 | 6 |
0.029 | 423093 | 5 |
0.030 | 2606187 | 11 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |